LingVo.club
Level
Biosensor reveals cancer-specific vulnerability in PRMT5 — Level A1 — blue and white abstract painting

Biosensor reveals cancer-specific vulnerability in PRMT5CEFR A1

28 Dec 2025

Adapted from Gregory Filiano-Stony Brook, Futurity CC BY 4.0

Photo by National Cancer Institute, Unsplash

Level A1 – Beginner
2 min
77 words
  • Cancer cells can change how a protein works.
  • The protein is called PRMT5 and acts in genes.
  • In some tumors PRMT5 binds a cancer molecule.
  • This binding is different from normal cells.
  • Scientists made a small sensor for live cells.
  • The sensor shows when drugs reach PRMT5.
  • The test helps find drugs that spare normal cells.
  • Many universities and funders supported the research.
  • This idea could make cancer drugs safer.
  • Researchers measured drug binding inside living cells.

Difficult words

  • proteinA molecule in cells that does many jobs
  • geneA piece of DNA that holds instructions
    genes
  • tumorA group of abnormal cells that may grow
    tumors
  • bindTo attach firmly to another molecule or part
    binds, binding
  • sensorA small device that detects and shows signals
  • drugA chemical used to treat or affect illness
    drugs

Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.

Discussion questions

  • Do you think safer cancer drugs are important?
  • Have you ever had a medical test?
  • Would you like medicines that do not hurt normal cells?

Related articles

Cancer survivors may age faster — Level A1
21 Jan 2026

Cancer survivors may age faster

A new study finds that adolescent and young adult cancer survivors show faster biological and brain aging than peers. The research links faster aging to memory and attention problems and tests ways to help survivors.

Biosensor reveals cancer-specific vulnerability in PRMT5 — English Level A1 | LingVo.club